SCHEMBL9385702

SCHEMBL9385702

CC1(C)CNC(=O)c2cc3nc(-c4ccncc4)[nH]c3cc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.59
PDE4B Q07343 1/20 0.59
PDE4C Q08493 1/20 0.59
PDE4D Q08499 1/20 0.59
PDE3B Q13370 1/20 0.59
PDE3A Q14432 1/20 0.59
CDC7 O00311 4/20 0.51
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
RHEB Q15382 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
PKN1 Q16512 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698021 0.88 NPBWR1 (0.47) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10700489 0.86 NPC1 (0.49) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL2455601 0.83 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9382103 0.82 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL2455602 0.80 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9384373 0.78 AURKA (0.39) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9380184 0.78 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9378614 0.78 KDM4E (0.53) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9705366 0.77 TP53 (0.42) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9379359 0.76 PDE3B (0.69) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0275888-B1 Tricyclic benzimidazoles, process for their preparation and use as medicaments BOEHRINGER MANNHEIM GMBH (DE) 1994-04-06 EP disclosed
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
US-4954498-A HYPOTENSIVE AGENTS, ANTICOAGULANTS, CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1990-09-04 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed